Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease

Otology and Neurotology

Volumn 29, Issue 6, 2008, Pages 816-823

  Jung, Jinsei ^a   Chun, Jeyoung ^a   Kim, Nahyun ^a   Kim, Younghoon ^b   Lee, Won Sang ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

M ni re's disease; Quality of life; Streptomycin

Indexed keywords

STREPTOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; LABYRINTHECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENIERE DISEASE; OCCUPATION; PATIENT SATISFACTION; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL STATUS; VERTIGO; DEMOGRAPHY; DRUG EFFECT; EARDRUM; INJECTION; MIDDLE AGED; PURE TONE AUDIOMETRY; QUESTIONNAIRE; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; DEMOGRAPHY; FEMALE; HUMANS; INJECTIONS; MALE; MENIERE DISEASE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STREPTOMYCIN; TYMPANIC MEMBRANE;

EID: 62349085316     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31817ef4e3     Document Type: Article

References (23)

1. Harner SG, Driscoll CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-4.
2. Van de Heyning PH, Wuyts F, Boudewyns A. Surgical treatment of Ménière's disease. Curr Opin Neurol 2005;18:23-8.
3. Minor LB. Intratympanic gentamicin for control of vertigo in Ménière's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
4. Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;110:1298-305.
5. Laitakari K. Intratympanic gentamycin in severe Ménière's disease. Clin Otolaryngol Allied Sci 1990;15:545-8.
6. Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Ménière's disease: results of therapy. Am J Otol 1997;18:52-7.
7. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55.
8. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
9. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Kinney SE, Sandridge SA, Newman CW. Long-term effects of Ménière's disease on hearing and quality of life. Am J Otol 1997; 18:67-73.
11. Yardley L, Masson E, Verschuur C, et al. Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale. J Psychosom Res 1992;36:731-41.
12. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990; 116:424-7.
13. Honrubia V, Bell TS, Harris MR, et al. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol 1996;17:595-602.
14. Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 1996;105:415-22.
15. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
16. Green JD Jr, Verrall A, Gates GA. Quality of life instruments in Ménière's disease. Laryngoscope 2007;117:1622-8.
17. Kato BM, LaRouere MJ, Bojrab DI, et al. Evaluating quality of life after endolymphatic sac surgery: the Ménière's disease outcomes questionnaire. Otol Neurotol 2004;25:339-44.
18. Murphy MP, Gates GA. Measuring the effects of Ménière's disease: results of the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol Rhinol Laryngol 1999;108:331-7.
19. Convert C, Franco-Vidal V, Bebear JP, et al. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients. Otol Neurotol 2006;27:687-96.
20. Diaz RC, LaRouere MJ, Bojrab DI, et al. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy. Otol Neurotol 2007;28:74-86.
21. Light JP, Silverstein H, Jackson LE. Gentamicin perfusion vestibular response and hearing loss. Otol Neurotol 2003;24:294-8.
22. Gottshall KR, Hoffer ME, Moore RJ, et al. The role of vestibular rehabilitation in the treatment of Ménière's disease. Otolaryngol Head Neck Surg 2005;133:326-8.
23. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Ménière's disease. Otolaryngol Clin North Am 2002;35: 675-82.